Algert Global’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-15,269
| Closed | -$231K | – | 1339 |
|
|
2022
Q3 | $231K | Sell |
15,269
-14,171
| -48% | -$165K | 0.01% | 1011 |
|
|
2022
Q2 | $221K | Buy |
+29,440
| New | +$207K | 0.02% | 998 |
|
|
2022
Q1 | – | Sell |
-15,233
| Closed | -$107K | – | 1356 |
|
|
2021
Q4 | $107K | Sell |
15,233
-3,310
| -18% | -$34.6K | 0.01% | 913 |
|
|
2021
Q3 | $211K | Sell |
18,543
-2,717
| -13% | -$39.7K | 0.03% | 894 |
|
|
2021
Q2 | $340K | Buy |
21,260
+4,470
| +27% | +$76.7K | 0.11% | 258 |
|
|
2021
Q1 | $300K | Buy |
16,790
+4,460
| +36% | +$77K | 0.1% | 301 |
|
|
2020
Q4 | $167K | Buy |
+12,330
| New | +$149K | 0.05% | 358 |
|
|
2020
Q3 | – | Sell |
-12,090
| Closed | -$178K | – | 510 |
|
|
2020
Q2 | $178K | Sell |
12,090
-1,535
| -11% | -$22.7K | 0.06% | 340 |
|
|
2020
Q1 | $184K | Buy |
+13,625
| New | +$259K | 0.08% | 309 |
|
Algert Global's AERI Position: Q4 2022 in Review
Algert Global sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 15,269 shares — an estimated $231K sold.
Algert Global first reported a position in AERI in Q1 2020 and held it in 9 quarters. The position peaked at $340K in Q2 2021. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Algert Global reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Algert Global sold 15,269 Aerie Pharmaceuticals shares in Q4 2022, an estimated $231K.
- Algert Global first reported a position in Aerie Pharmaceuticals in Q1 2020 and held it in 9 quarters.
- Algert Global's Aerie Pharmaceuticals position peaked at $340K in Q2 2021.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Algert Global's 13F filing for Q4 2022, filed 14 Feb 2023.